198 related articles for article (PubMed ID: 26656689)
41. Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells.
Regan AD; Cohen RD; Whittaker GR
Virology; 2009 Feb; 384(1):135-43. PubMed ID: 19058829
[TBL] [Abstract][Full Text] [Related]
42. The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals.
Wang F; Chen C; Wang Z; Han X; Shi P; Zhou K; Liu X; Xiao Y; Cai Y; Huang J; Zhang L; Yang H
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336895
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats.
Takano T; Tomizawa K; Morioka H; Doki T; Hohdatsu T
Antivir Ther; 2014; 19(7):645-50. PubMed ID: 24458025
[TBL] [Abstract][Full Text] [Related]
44. A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism.
Ho CY; Yu JX; Wang YC; Lin YC; Chiu YF; Gao JY; Lai SJ; Chen MJ; Huang WC; Tien N; Chen Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628479
[TBL] [Abstract][Full Text] [Related]
45. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design.
Xue X; Yu H; Yang H; Xue F; Wu Z; Shen W; Li J; Zhou Z; Ding Y; Zhao Q; Zhang XC; Liao M; Bartlam M; Rao Z
J Virol; 2008 Mar; 82(5):2515-27. PubMed ID: 18094151
[TBL] [Abstract][Full Text] [Related]
46. The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor.
Cui W; Cui S; Chen C; Chen X; Wang Z; Yang H; Zhang L
Biochem Biophys Res Commun; 2019 Apr; 511(4):794-799. PubMed ID: 30833083
[TBL] [Abstract][Full Text] [Related]
47. Recent developments on coronavirus main protease/3C like protease inhibitors.
Zhao Q; Weber E; Yang H
Recent Pat Antiinfect Drug Discov; 2013 Aug; 8(2):150-6. PubMed ID: 23879823
[TBL] [Abstract][Full Text] [Related]
48. Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP.
Tseng YY; Liao GR; Lien A; Hsu WL
Comput Struct Biotechnol J; 2021; 19():1072-1080. PubMed ID: 33552444
[TBL] [Abstract][Full Text] [Related]
49. Virologic and immunologic aspects of feline infectious peritonitis virus infection.
Pedersen NC
Adv Exp Med Biol; 1987; 218():529-50. PubMed ID: 2829567
[TBL] [Abstract][Full Text] [Related]
50. Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro).
Bacha U; Barrila J; Gabelli SB; Kiso Y; Mario Amzel L; Freire E
Chem Biol Drug Des; 2008 Jul; 72(1):34-49. PubMed ID: 18611220
[TBL] [Abstract][Full Text] [Related]
51. Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element.
Galasiti Kankanamalage AC; Kim Y; Damalanka VC; Rathnayake AD; Fehr AR; Mehzabeen N; Battaile KP; Lovell S; Lushington GH; Perlman S; Chang KO; Groutas WC
Eur J Med Chem; 2018 Apr; 150():334-346. PubMed ID: 29544147
[TBL] [Abstract][Full Text] [Related]
52. Detection of anti-feline infectious peritonitis virus activity of a Chinese herb extract using geneLEAD VIII, a fully automated nucleic acid extraction/quantitative PCR testing system.
Nishijima R; Endo T; Gankhuyag E; Khin STMM; Jafar SM; Shinohara Y; Tanaka Y; Sawakami K; Yohda M; Furuya T
J Vet Med Sci; 2023 Mar; 85(4):443-446. PubMed ID: 36806247
[TBL] [Abstract][Full Text] [Related]
53. Characterization and inhibition of SARS-coronavirus main protease.
Liang PH
Curr Top Med Chem; 2006; 6(4):361-76. PubMed ID: 16611148
[TBL] [Abstract][Full Text] [Related]
54. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters.
Verschueren KH; Pumpor K; Anemüller S; Chen S; Mesters JR; Hilgenfeld R
Chem Biol; 2008 Jun; 15(6):597-606. PubMed ID: 18559270
[TBL] [Abstract][Full Text] [Related]
55. Feline Coronavirus Antivirals: A Review.
Delaplace M; Huet H; Gambino A; Le Poder S
Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578182
[TBL] [Abstract][Full Text] [Related]
56. Structural and Biological Basis of Alphacoronavirus nsp1 Associated with Host Proliferation and Immune Evasion.
Shen Z; Yang Y; Yang S; Zhang G; Xiao S; Fu ZF; Peng G
Viruses; 2020 Jul; 12(8):. PubMed ID: 32731335
[TBL] [Abstract][Full Text] [Related]
57. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
Lee TW; Cherney MM; Huitema C; Liu J; James KE; Powers JC; Eltis LD; James MN
J Mol Biol; 2005 Nov; 353(5):1137-51. PubMed ID: 16219322
[TBL] [Abstract][Full Text] [Related]
58. Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans.
Yang TJ; Chang YC; Ko TP; Draczkowski P; Chien YC; Chang YC; Wu KP; Khoo KH; Chang HW; Hsu SD
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1438-1446. PubMed ID: 31900356
[TBL] [Abstract][Full Text] [Related]
59. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs.
Zhang XW; Yap YL
Bioorg Med Chem; 2004 May; 12(10):2517-21. PubMed ID: 15110833
[TBL] [Abstract][Full Text] [Related]
60. Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection.
Takano T; Satoh K; Doki T
Front Vet Sci; 2021; 8():647189. PubMed ID: 33644160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
